A Single-Dose Study of LY3471851 in Healthy Participants

NCT04998487 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

71

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: LY3471851

Sponsor

Nektar Therapeutics

Collaborators

[object Object]